VANCOUVER, BC / May 31, 2024 / TheNewswire / AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or “the Company”) Arev Life Sciences Global Corp (CSE: AREV, US AREVF), a leading innovator in the life sciences, is pleased to announce its strong support for the recent passage of Bill C-368 in the Canadian Parliament. This landmark legislation amends the Food and Drugs Act to ensure that natural health products... Read More

Vancouver, BC - TheNewswire - June 26, 2023 - AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the Company ”) AREV Life Sciences did not file its annual financial statements and management’s discussion & analysis for the fiscal year ended December 31, 2022, by the filing deadline of April 30, 2023, and as a result is in default of its obligations under Part 4 of National Instrument 51-102 Continuous... Read More

VANCOUVER, BC – TheNewswire - June 12, 2023 - AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the Company”) AREV Life Sciences did not file its annual financial statements and management’s discussion & analysis for the fiscal year ended December 31, 2022, by the filing deadline of April 30, 2023, and as a result is in default of its obligations under Part 4 of National Instrument 51-102 Continuous... Read More

Arev Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the Company ”) AREV Life Sciences did not file its annual financial statements and management’s discussion & analysis for the fiscal year ended December 31, 2022, by the filing deadline of April 30, 2023, and as a result is in default of its obligations under Part 4 of National Instrument 51-102 Continuous Disclosure Obligations. The Company has requested from... Read More

Vancouver, BC - TheNewswire - May 9, 2023 - AREV Life Sciences Global Corp . (CSE:AREV) (OTC:AREVF) (“ AREV ” or the Company ”) AREV Life Sciences is pleased to announce it has completed its first phase of AI driven deductive research to identify the best complimentary natural compounds for use with its proprietary extracts and Combination Therapy in traditional medicine. Arev has written and refined an exclusive library of... Read More

VANCOUVER, BC – TheNewswire - April 27, 2023 - AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces today that it will miss its filing deadline of April 30, 2023, to file its audited annual financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the year ended December 31, 2022... Read More

VANCOUVER, BC – TheNewswire - March 27, 2023 - AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces it has terminated the term sheet to acquire Fiberlab, Inc, A Nevada Corporation with operations in downtown Los Angeles and Europe. The company also announces that it has terminated the previously announced Private Placement. The company has terminated... Read More

Vancouver, BC - TheNewswire - March 15, 2023 - AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation is pleased to announce it has signed a term sheet on March 14, 2023 to acquire Fiberlab, Inc, a Nevada Corporation with operations in downtown Los Angeles and Europe. Fiberlab has developed the proprietary protocols with a closed-loop filtration and isolation... Read More

Vancouver, BC - TheNewswire - February 28, 2023 - AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences is pleased to provide a corporate update covering the last 12 months and into early 2023. Throughout fiscal year 2022, Arev continued to focus and execute on its strategy to innovate, commercialize, and offer unique products specializing in clinical nutrition, proprietary... Read More

VANCOUVER, BC – TheNewswire - February 15, 2023 - AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation is pleased to announce it has commenced research to identify advanced isolation technology for its proprietary extract after learning results of a new study on Hericium erinaceus extract from Lions Mane. Using super-resolution microscopy, the team from The... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces today the resignation of Melvin Maxwell. The Company announces the resignation of Mr. Melvin Maxwell. The Company would like to thank Mr. Maxwell for his efforts on behalf of the Company and wish him well in his future endeavors. For further information, contact Mike Withrow, mike@AREVBrands.com... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation is pleased to announce the outcome of the votes at the annual meetings of the shareholders of AREV held on January 4, 2022 in Vancouver, British Columbia. On January 4, 2023, AREV held its Annual General Meeting; the results follow: Item 1: Number of Directors The number of Directors was set to the election... Read More

VANCOUVER, BC / TheNewswire / November 9 , 2022 / AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces today it has settled $50,000.00 in debt with Chiron Capital Inc, a Company wholly owned by a Director of the Company, by the issuance of 500,000 Shares at $0.10. Participation of the insiders of the Company in the shares for debt constitutes a... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces today it has settled $50,000.00 in debt with Chiron Capital Inc, a Company wholly owned by a Director of the Company, by the issuance of 500,000 Shares at $0.10. Participation of the insiders of the Company in the shares for debt constitutes a related party transaction as defined under Multilateral... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce the appointment of Dr. Andrew Levinson to the company’s Scientific Advisory Board. Dr. Levinson is dedicated to progressive direction in integrative health, Dr. Levinson is a functional medicine doctor and psychiatrist combining mainstream and alternative approaches together with comprehensive treatments. He has developed... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation applauds The U.S. Government for its recent announcement to support global food insecurity. On September 21st the U.S. government announced over $2.9 billion in new assistance to address global food insecurity. President Biden’s announcement builds on the $6.9 billion in U.S. government assistance to support... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces today the coverage of in HealthHIV.org Article titled Another Horseman. The article can be read at https://healthhiv.org/resource/another-horseman/ . The article articulates the need to aggressively address the use of Ready to Use Therapeutic Foods to treat Serious & Acute... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation AREV Life Sciences Global Corporation announces the appointment of Sateesh Apte MD to the Scientific Advisory Board (the “SAB”) of AREV. AREV Life Sciences announced the appointment of Sateesh Apte MD to its Scientific Advisory Board, as part of the current scale up for launching clinical... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces a corporate update on progress of its business streams. Arev, like many other companies, has felt the impact of the lock downs and changes in market conditions as a result of Covid-19, the war in Ukraine and now global inflation. We believe AREV is very well positioned to make a positive impact in... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) AREV Life Sciences Global Corporation announces a corporate update on progress of its business streams. Arev, like many other companies, has felt the impact of the lock downs and changes in market conditions as a result of Covid-19, the war in Ukraine and now global inflation. We believe AREV is very well positioned to make a... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce the following commentary on the growing global food security crisis on Yahoo Finance by Admiral James Stavridis, former Supreme Allied Commander, NATO, current Vice Chair, Global Affairs and Managing Director the Carlyle Group , and Chair of the Board of Trustees of the Rockefeller Foundation , along with recent testimony... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce the issuance of the retention warrant offering as announced April 8, 2022. AREV is pleased to announce a retention warrant offering to its senior management of Mike Withrow, CEO, and Kevin Phelps, COO. Each of the retention warrants are being sold to the purchase price of $0.05 per retention share purchase warrant and... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) ( “ AREV” or the “ Company ”) AREV announced today its initial research engagement with TransBIOTech. Created in 1999, TransBIOTech, a publicly-supported preclinical research organization that works in partnership with and is supported by the Canadian government through the Natural Sciences and Engineering Research Council (NSERC) in collaboration with the Canadian... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company” ) AREV Life Sciences Global Corporation announced today the appointment of Brian V. Elliott, B Comm to its Board of Directors. In the pursuit of innovative global health solutions, AREV Life Sciences Global Corporation adds Brian V. Elliott , among its Board of Directors. Brian V. Elliott is an international strategist and leader exhibiting over... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company” ) AREV Life Sciences Global Corporation announced today the appointment of Kevin Phelps, CPA as Chief Operating Officer. In its current phase of growth and development, AREV Life Sciences Global Corporation appoints Kevin Phelps, CPA and AREV Board Member to the role of Chief Operating Officer. Kevin Phelps brings 40 years of experience in... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company” ) AREV Life Sciences Global Corporation announced today the appointment of Kevin Phelps, CPA as Chief Operating Officer. In its current phase of growth and development, AREV Life Sciences Global Corporation appoints Kevin Phelps, CPA and AREV Board Member to the role of Chief Operating Officer. Kevin Phelps brings 40 years of experience in... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company” ) AREV Life Sciences Global Corporation announced today the appointment of Kevin Phelps, CPA as Chief Operating Officer. In its current phase of growth and development, AREV Life Sciences Global Corporation appoints Kevin Phelps, CPA and AREV Board Member to the role of Chief Operating Officer. Kevin Phelps brings 40 years of experience in... Read More

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company” ) AREV Life Sciences announced today it has engaged the University of Manitoba, Richardson Centre for Functional Foods and Nutraceuticals to complete the design and produce the prototypes of its Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs “SUSTAINN”, AREV’s next generation Ready to Use Therapeutic Food... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (“AREV” or the “Company” ) announced today completion of its fungi inoculation lab, colonizing and fruiting rooms. The fruiting room has been populated with colonized blocks of Lions Mane ( Hericium erinaceus) containing bioactive substances with beneficial effects on the body, especially the brain, heart and gut. Over the past 3 months Arev has been building its fungi... Read More

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) today announces its new corporate acquisitions and maturation of multiple product lines that are being matched with appointments and expanding corporate capacity in the Company’s scientific advisory committee and IP council. The Company is pleased to announce the appointment of Douglas Sorocco to its scientific advisory committee and IP... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce a recent study by Richard Van Breeman PhD, a member of AREV’s Scientific Advisory Board (SAB), along with collaborators at Oregon State University’s (OSU) College of Pharmacy, the Linus Pauling Institute and OSU’s Global Hemp Innovation Center, published in the January edition of the Journal of Natural... Read More

AREV LIFE SCIENCES GLOBAL CORP. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) is pleased to announce the appointment of Allan Echino as Director effective December 21, 2021 and Denby Greenslade as interim Chief Financial Officer (“CFO”), effective December 17, 2021. Allan Echino began his entrepreneurial experience as a youngster, working in the family business in Kamloops, BC. As well as other business... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” ) is pleased to announce that it has reached a confidential settlement with Matthew Harvey, the vendor of the BC Bud Depot Assets, during a formal mediation prior to Trial. The Company announced on January 31, 2020 that the Company had commenced litigation in the Supreme Court of British Columbia over the breaches of Agreement by the Defendant,... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV”) is pleased to announce that it has received the lab test results from the Hericium Erinaceus from its Joint Venture partner Absolem Mushroom Extraction Inc. (a subsidiary of Absolem Health Inc.). The Company used green solvents suitable for extraction of functional and medicinal fungi and designed a method for the extraction of active compounds... Read More

AREV Life Sciences Global Corp. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV” or the “Company” ) is pleased to announce the Company has closed on the purchase of Wright and Well Essentials Inc. (“Wright & Well”) in an all cash deal. AREV Life Sciences Global Corp. has purchased Wright & Well, a company with an extensive Hemp and Cannabis line of branded products currently being sold in 10 d ispensaries in Oregon . The... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.C N ) (OTC:AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce t he Company has issued 700,000 stock options to Directors, Officers and Consultants of the Company at a price of $0. 12 for a period of 5 years from the issuance dated. These options will vest immediately. The Company is also pleased to announce it has settled $10,000 in debt with Chiron Capital Inc, a Company... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) announces that the Company has entered into a collaborative development agreement with Voynich Biosciences, Inc. (“Voynich”) that further advances AREV’s flagship initiative, the next-generation Ready-to-Use Therapeutic Food (“RUTF”), SUS-TAINN™. Voynich is an early-stage, privately-held, phytomedicinal discovery company headquartered in... Read More

AREV LIFE SCIENCES GLOBAL CORP . (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce Brian Cameron as Chief Financial Officer (“CFO”), effective September 2, 2021. Mr. Cameron has owned and operated a corporate finance consultancy, Cameron & Associates, since 1983, with offices in Vancouver Canada, Seattle Washington and Phoenix, Arizona. Prior to forming Cameron & Associates, Mr. Cameron was employed... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company” ) is pleased to announce the Company’s will be changing their name from AREV Nanotec Brands Inc. to AREV Life Sciences Global Corp. The Company's new CUSIP number and ISIN for the Shares will be 04019J109 and CA04019J1093, respectively. As per the Canadian Stock Exchange policy the Company will not be changing its trading symbol. The... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company”) announces that the Company has entered into a collaborative development agreement with Voynich Biosciences, Inc. (“Voynich”) that further advances AREV’s flagship initiative, the next-generation Ready-to-Use Therapeutic Food (“RUTF”), SUS-TAINN™. Voynich is an early-stage, privately-held, phytomedicinal discovery company headquartered in... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announces that the Company has entered into a collaborative development agreement with Voynich Biosciences, Inc. (“Voynich”) that further advances AREV’s flagship initiative, the next-generation Ready-to-Use Therapeutic Food (“RUTF”), SUS-TAINN™. Voynich is an early-stage, privately-held, phytomedicinal discovery company headquartered in Hawaii and... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company” ) is pleased to announce the Company’s RUTF product development premise has been validated. Recent data presented this week on the co-intersection of HIV and nutrition at the 11th International AIDS Society Conference on HIV Science (IAS 2021), held virtually with a hub in Berlin, demonstrates the need for innovation in the universal... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company’s RUTF product development premise has been validated. Recent data presented this week on the co-intersection of HIV and nutrition at the 11th International AIDS Society Conference on HIV Science (IAS 2021), held virtually with a hub in Berlin, demonstrates the need for innovation in the universal address of famine,... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV” or the “Company”) is pleased to announce the outcome of the votes at the annual and special meetings of the shareholders of AREV Nanotec Brands Inc. held on July 13, 2021 in Vancouver, British Columbia. In addition, on July 17, 2021, the AREV Board of Directors appointed U.S. entrepreneur Mr. Melvin S. Maxwell III as a new Director of the Company. Mr.... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the outcome of the votes at the annual and special meetings of the shareholders of AREV Nanotec Brands Inc. held on July 13, 2021 in Vancouver, British Columbia. In addition, on July 17, 2021, the AREV Board of Directors appointed U.S. entrepreneur Mr. Melvin S. Maxwell III as a new Director of the Company. Mr. Maxwell’s... Read More

BYND Cannasoft Enterprises Inc. (“BYND” or the “Company”) is pleased to announce that it has closed its previously announced, non-brokered private placement financing (see press release dated June 21, 2021). In connection with the financing, the Company issued 2,000,000 common shares to a single investor at an issue price of $0.92 per share, raising $1,840,000 of gross proceeds. The common shares issued in connection with... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) is pleased to announce the Company has established a wholly owned U.S. subsidiary with offices in Rochester, New York. AREV’s formation of Rochester-based AREV Life Sciences Inc., a Delaware corporation (“AREV Life Sciences”), is a successful milestone in the growth strategy of AREV. The subsidiary’s placement in Rochester, New York has multiple... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce the Company has completed its land survey and soil analysis for cultivation of mushrooms, moringa and breadfruit. Mr. Rem Sareub, Head of Agriculture for AREV Cambodia has completed the soil and land survey of the company’s 20 hectare leased land parcel in the Stoung District of... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce the Company has completed its land survey and soil analysis for cultivation of mushrooms, moringa and breadfruit. Mr. Rem Sareub, Head of Agriculture for AREV Cambodia has completed the soil and land survey of the company’s 20 hectare leased land parcel in the Stoung District of Cambodia.... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or the “Company” ) is pleased to announce that its Chief Executive Officer, Michael Withrow, has purchased a total of 900,000 shares, including private placement purchases and the exercising of warrants. Mr. Withrow purchased, through his wholly owned entity, Chiron Capital Inc., the shares by exercising 500,000 warrants at a price of $0.08 per warrant... Read More

AREV Nanotech Brands, Inc. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) ("AREV" or the “Company"), a publicly traded life science enterprise, and Germinator, leading sanitizing and disinfecting company, have entered into a definitive agreement to provide the Genesis hypochlorous acid (HOCl) platform of surface disinfection to global public health commodity procurement programs to aid refugees and Internally Displaced Persons (IDPs)... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV”) is pleased to announce the appointment of Dr. Harold C. Smith to its Scientific Advisory Board. Dr. Harold Smith is the founder, CEO, and president of OyaGen, Inc. (“OyaGen”), a biotechnology company developing therapeutics for infectious diseases and cancer. Dr. Smith also is a full professor of biochemistry and biophysics at the University of Rochester, School of... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (“AREV Brands”) announced today that the Management Cease Trade Order (“MCTO”) imposed by the British Columbia Securities Commission (“BCSC”) has been revoked. With this resolution of the MCTO, members of management are no longer precluded from trading the Company’s common shares. On May 4, 2021, the Company announced that it had been granted an MCTO by the BCSC. The... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV); (CNSX:AREV.CN); (OTC:AREVF) (”AREV” or the “Company”) Is pleased to announce it has expanded its extraction results to Clinical Characterization of Compounds and provides this update of corporate developments consistent with its news announcements and AREV’s transformed corporate website now located at www.arevlifesciences.com . The Company encourages its shareholders and interested... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (“AREV Brands”) is providing a biweekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). AREV Nanotec Brands Inc. (“the Company”) did not file its audited annual financial statements and MD&A for the period ended December 31, 2020 by the filing deadline of April 29, 2021 and as a result is in default of its... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (“AREV Brands”) announces that will not be able to file its audited annual financial statements for the period ended December 31, 2020 and its MD&A by the filing deadline of April 29, 2021 and as a result will be in default of its obligations under National Instrument 51-102 Continuous Disclosure Obligations . The Company has encountered difficulties in completing the audit... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV” or “the Company”) is pleased to announce that on March 31, 2021, the Company signed, a Collaboration and Exclusivity Agreement (“the Collaboration Agreement”) with one of the world’s leading hemp-derived cannabinoid product developers and producers (“Collaboration Co”). Under the Collaboration Agreement, Collaboration Co. will be AREV’s exclusive supplier... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Brands”) announces the Company has closed $670,000 of the previously announced up to $725,000 Private Placement. The non-brokered private placement of up to 2,680,000 Units of the Company (the “Units”) at a price of CAD$0.25 per Unit, for gross proceeds of CAD$670,000 (the “Financing”). Each Unit will consist of one common Share and one common share... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Nanotec” or “AREV”) is pleased to announce that the Company has become a member of BIOTECanada. Since 1988, BIOTECanada, the national industry association representing Canada’s biotechnology sector, has been the leading voice for the life science industry and works to advance the development of a globally competitive Canadian biotechnology ecosystem... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Nanotec” or “AREV”) is pleased to announce that the Company has appointed Chad S. Johnson, Esq., as Special Counsel for Corporate Development. Complementing AREV’s announced corporate and development activities, Mr. Johnson and his staff will serve AREV in a variety of capacities, including media strategy development, government affairs and legislative... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Nanotec” or “AREV”) announces that the Company will hold a video conference on Friday, March 12, 2021 at 1 pm PST (4 pm EST), to update on recent corporate initiatives in the life science industry, including a review of its new relationships within the biotechnology industry and establishment of its Scientific Advisory Board (SAB) and related appointments,... Read More

AREV NANOTEC BRANDS INC. (C NSX :AREV. CN ) (OTC:AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors. Mr. Phelps has a long history in the biotechnology and drug discovery industries, currently serving as the CEO of Immune Therapeutics, Inc. (IMUN), a publicly-traded company focused on mid-stage immune-based therapies, and as Chairman of OyaGen, Inc., a... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce that the Company has become a member of BIO, the Biotechnology Innovation Group, which is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other countries. BIO is committed to... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors. Mr. Phelps has a long history in the biotechnology and drug discovery industries, currently serving as the CEO of Immune Therapeutics, Inc. (IMUN), a publicly-traded company focused on mid-stage immune-based therapies, and as Chairman of OyaGen, Inc., a privately-held... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce that the Company has become a member of BIO, the Biotechnology Innovation Group, which is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other countries. BIO is committed to... Read More

AREV NANOTEC BRANDS INC. (C NSX :AREV. CN ) (OTC:AREVF) (“AREV Nanotec” or “AREV”) is pleased to announce its subsidiary AREV Cambodia Brands Inc. has initiated the first of several steps to setting up a permaculture operation on 20 hectares of land near Phnom Penh to support the development of the raw materials for product innovations in development for introduction to market in the 3rd Quarter of 2021. Our first product... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Brands” ) is pleased to announce the appointment of Dr. Jay Noller to its Scientific Advisory Board. Dr. Jay Noller, PhD, is a globally recognized polymath in agriculture, environmental and earth sciences, archaeology, and visual arts. He has led organizations that provided diverse activities in education, research, extension, and public service relevant... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Nanotec”) , is pleased to announce that AREV is utilizing its proprietary extraction technologies and facilitating initial efforts to identify broad spectrum antiviral agents derived from medicinal photochemistry sources including bioactive compounds sourced from Moringa oleifera and Moringa ovalifolia , identified in peer-reviewed publications as... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec”), is pleased to announce that AREV is utilizing its proprietary extraction technologies and facilitating initial efforts to identify broad spectrum antiviral agents derived from medicinal photochemistry sources including bioactive compounds sourced from Moringa oleifera and Moringa ovalifolia , identified in peer-reviewed publications as presenting a wide... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Nanotec”) , which recently introduced its nanotechnology extraction system to the world, is looking even further to the future, but this time has its sights set on helping to improve food security by way of hemp protein. (https://gvn.org/about/board/) As such, AREV is a sponsor of the inaugural National Hemp Symposium , a joint initiative between the... Read More

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is pleased to announce the appointment of Dr. Roscoe Moore DVM, MPH, PhD, Former Assistant United States Surgeon General to the Scientific Advisory Board for AREV Nanotec Brands Inc, to provide strategic planning for AREV drug discovery planning, as a Senior Scientific Advisor. Dr. Moore is a Board member of the Board of Advisors and the Board of Directors of... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (OTC:AREVF) (CNSX:AREV.CN) (“AREV Brands”) is pleased to announce the appointment of Dr. Roscoe Moore DVM, MPH, PhD, Former Assistant United States Surgeon General to the Scientific Advisory Board for AREV Nanotec Brands Inc, to provide strategic planning for AREV drug discovery planning, as a Senior Scientific Advisor. Dr. Moore is a Board member of the Board of Advisors and the Board of... Read More

AREV NANOTEC BRANDS INC. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) (“AREV Brands” ) Corporate update on its continued work with natural materials, specifically Moringa. The company has been working with several plant, fungi and marine biomass including functional mushrooms, hops, frankincense, myrrh, Kampot pepper, sea cucumber, ginseng and Moringa. Much of this work has been focused on the best way to extract actives and... Read More